• 1
    Dome P, Teleki Z, Rihmer Z et al. Circulating endothelial progenitor cells and depression: A possible novel link between heart and soul. Mol. Psychiatry 2008 Jan 8 doi:10.1038/
  • 2
    Yang K, Xie G, Zhang Z et al. Levels of serum interleukin (IL)-6, IL-1beta, tumour necrosis factor-alpha and leptin and their correlation in depression. Aust. N. Z. J. Psychiatry 2007; 41: 266273.
  • 3
    Raison CL, Capuron L, Miller AH. Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol. 2006; 27: 2431.
  • 4
    Brietzke E, Kapczinski F. TNF-alpha as a molecular target in bipolar disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008; 32: 13551361.
  • 5
    Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2000; 22: 370379.
  • 6
    Himmerich H, Binder EB, Kunzel HE et al. Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis. Biol. Psychiatry 2006; 60: 882888.
  • 7
    Kim YK, Lee SW, Kim SH et al. Differences in cytokines between non-suicidal patients and suicidal patients in major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008; 32: 356361.
  • 8
    Vandenabeele P, Declercq W, Beyaert R, Fiers W. Two tumour necrosis factor receptors: Structure and function. Trends Cell Biol. 1995; 5: 392399.
  • 9
    Diez-Ruiz A, Tilz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur. J. Haematol. 1995; 54: 18.
  • 10
    Chen G, Goeddel DV. TNF-R1 signaling: A beautiful pathway. Science 2002; 296: 16341635.
  • 11
    Carpentier I, Coornaert B, Beyaert R. Function and regulation of tumor necrosis factor type 2. Curr. Med. Chem. 2004; 11: 22052212.
  • 12
    Granell S, Pereda J, Gomez-Cambronero L et al. Circulating TNF-alpha and its soluble receptors during experimental acute pancreatitis. Cytokine 2004; 25: 187191.
  • 13
    Pouly S, Antel JP, Ladiwala U, Nalbantoglu J, Becher B. Mechanisms of tissue injury in multiple sclerosis: Opportunities for neuroprotective therapy. J. Neural Transm. Suppl. 2000; (58): 193203.
  • 14
    Alaaeddine N, DiBattista JA, Pelletier JP et al. Osteoarthritic synovial fibroblasts possess an increased level of tumor necrosis factor-receptor 55 (TNF-R55) that mediates biological activation by TNF-alpha. J. Rheumatol. 1997; 24: 19851994.
  • 15
    Kronfol Z, Remick DG. Cytokines and the brain: Implications for clinical psychiatry. Am. J. Psychiatry 2000; 157: 683694.
  • 16
    Friebe A, Schwarz MJ, Schmid-Wendtner M et al. Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanoma. J. Immunother. 2007; 30: 333337.
  • 17
    Moorman AJ, Mozaffarian D, Wilkinson CW et al. In patients with heart failure elevated soluble TNF-receptor 1 is associated with higher risk of depression. J. Card. Fail. 2007; 13: 738743.
  • 18
    Veenema AH, Reber SO, Selch S, Obermeier F, Neumann ID. Early life stress enhances the vulnerability to chronic psychosocial stress and experimental colitis in adult mice. Endocrinology 2008; 149: 27272736.
  • 19
    von Kanel R, Hepp U, Kraemer B et al. Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J. Psychiatr. Res. 2007; 41: 744752.
  • 20
    Danese A, Moffitt TE, Pariante CM, Ambler A, Poulton R, Caspi A. Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch. Gen. Psychiatry 2008; 65: 409415.
  • 21
    Danese A, Pariante CM, Caspi A, Taylor A, Poulton R. Childhood maltreatment predicts adult inflammation in a life-course study. Proc. Natl Acad. Sci. USA 2007; 104: 13191324.
  • 22
    Cirino PT, Chin CE, Sevcik RA, Wolf M, Lovett M, Morris RD. Measuring socioeconomic status: Reliability and preliminary validity for different approaches. Assessment 2002; 9: 145155.
  • 23
    Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961; 4: 561571.
  • 24
    Gorenstein C, Andrade L. Validation of a Portuguese version of the Beck Depression Inventory and the State-Trait Anxiety Inventory in Brazilian subjects. Braz. J. Med. Biol. Res. 1996; 29: 453457.
  • 25
    Lang AJ, Laffaye C, Satz LE, Dresselhaus TR, Stein MB. Sensitivity and specificity of the PTSD checklist in detecting PTSD in female veterans in primary care. J. Trauma. Stress 2003; 16: 257264.
  • 26
    Berger W, Mendlowicz MV, Souza W, Figueira I. Semantic equivalence of the Portuguese version of the Post-Traumatic Stress Disorder Checklist–Civilian Version (PCL-C) for the screening of post-traumatic stress disorder. Rev. Psiquiatr. Rio Gd Sul 2004; 26: 167175.
  • 27
    Bernstein DP, Stein JA, Newcomb MD et al. Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse Negl. 2003; 27: 169190.
  • 28
    Grassi-Oliveira R, Stein LM, Pezzi JC. Translation and content validation of the Childhood Trauma Questionnaire into Portuguese language. Rev. Saude Publica 2006; 40: 249255.
  • 29
    Alessandri AL, Souza AL, Oliveira SC, Macedo GC, Teixeira MM, Teixeira AL. Concentrations of CXCL8, CXCL9 and sTNFR1 in plasma of patients with pulmonary tuberculosis undergoing treatment. Inflamm. Res. 2006; 55: 528533.
  • 30
    Fontaine V, Mohand-Said S, Hanoteau N, Fuchs C, Pfizenmaier K, Eisel U. Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: Opposite roles of TNF receptor 1 and TNF receptor 2. J. Neurosci. 2002; 22: 17.
  • 31
    Marchetti L, Klein M, Schlett K, Pfizenmaier K, Eisel UL. Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway. J. Biol. Chem. 2004; 279: 3286932881.
  • 32
    Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003; 10: 4565.
  • 33
    Beg AA, Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996; 274: 782784.
  • 34
    Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc. Natl Acad. Sci. USA 1992; 89: 48454849.
  • 35
    Leonard BE. Inflammation, depression and dementia: Are they connected? Neurochem. Res. 2007; 32: 17491756.
  • 36
    Loftis JM, Huckans M, Ruimy S, Hinrichs DJ, Hauser P. Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha. Neurosci. Lett. 2008; 430: 264268.
  • 37
    Porteu F, Nathan C. Shedding of tumor necrosis factor receptors by activated human neutrophils. J. Exp. Med. 1990; 172: 599607.
  • 38
    Hasegawa Y, Sawada M, Ozaki N, Inagaki T, Suzumura A. Increased soluble tumor necrosis factor receptor levels in the serum of elderly people. Gerontology 2000; 46: 185188.
  • 39
    Muller N, Schwarz MJ, Dehning S et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: Results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol. Psychiatry 2006; 11: 680684.
  • 40
    Nery FG, Monkul ES, Hatch JP et al. Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: A double-blind, randomized, placebo-controlled study. Hum. Psychopharmacol. 2008; 23: 8794.